Neuroone Medical Technologies (NMTC) EPS (Basic) Growth (3y) (2013 - 2026)
Neuroone Medical Technologies (NMTC) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.23 Bn | 196.63 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.28 Bn | 123.80 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 119.00 Bn | 109.78 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 74.41 Bn | 73.88 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.77 Bn | 47.52 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 35.03 Bn | 33.09 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.80 Bn | 31.69 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.24 Bn | 22.92 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.20 Bn | 22.71 Bn | 684.20 Mn | 17.98% |
| 10 | Neuroone Medical Technologies | 18.19 Mn | 16.14 Mn | 1.18 Mn | 41.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.55% |
| Mar 31, 2026 | 39.81% |
| Dec 31, 2025 | 35.56% |
| Sep 30, 2025 | 22.28% |
| Jun 30, 2025 | 43.41% |
| Mar 31, 2025 | 27.17% |
| Dec 31, 2024 | 32.34% |
| Sep 30, 2024 | 51.10% |
| Jun 30, 2024 | 25.71% |
| Mar 31, 2024 | 19.73% |
| Dec 31, 2023 | 18.59% |
| Sep 30, 2023 | -27.75% |
| Jun 30, 2023 | 47.01% |
| Mar 31, 2023 | 9.58% |
| Dec 31, 2022 | 52.85% |
| Sep 30, 2022 | 36.93% |
| Jun 30, 2022 | 26.16% |
| Mar 31, 2022 | 32.15% |
| Jun 30, 2021 | 40.26% |
| Mar 31, 2021 | 33.17% |